Fmr LLC Candel Therapeutics, Inc. Transaction History

Fmr LLC

$1.49 Trillion
Q1 2025

A detailed history of Fmr LLC transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 7,085,316 shares of CADL stock, worth $41.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,085,316

Previous 3,923,599 80.58%

Holding current value

$41.7 Million

Previous $34.1 Million 17.55%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$5.65 - $12.21 $17.9 Million - $38.6 Million	3,161,717 Added 80.58%	7,085,316 $40 Million
Q4 2024 Feb 13, 2025	BUY	$3.96 - $9.96 $15.5 Million - $39 Million	3,917,026 Added 59592.67%	3,923,599 $34.1 Million
Q3 2024 Nov 13, 2024	BUY	$5.02 - $7.76 $32,996 - $51,006	6,573 New	6,573 $45,000
Q4 2023 Feb 13, 2024	SELL	$0.68 - $1.47 $95,658 - $206,790	-140,674 Reduced 32.04%	298,384 $438,000
Q3 2023 Nov 13, 2023	SELL	$0.91 - $1.3 $12,284 - $17,548	-13,499 Reduced 2.98%	439,058 $403,000
Q2 2023 Aug 11, 2023	SELL	$1.2 - $1.78 $192,720 - $285,868	-160,600 Reduced 26.19%	452,557 $570,000
Q1 2023 May 11, 2023	SELL	$1.35 - $2.72 $167,992 - $338,474	-124,439 Reduced 16.87%	613,157 $827,000
Q4 2022 Feb 13, 2023	SELL	$1.48 - $3.2 $239,468 - $517,769	-161,803 Reduced 17.99%	737,596 $1.32 Million
Q2 2022 Aug 12, 2022	SELL	$3.13 - $5.56 $3.36 Million - $5.96 Million	-1,072,827 Reduced 54.4%	899,399 $2.91 Million
Q1 2022 May 13, 2022	SELL	$3.66 - $8.0 $1.06 Million - $2.32 Million	-290,616 Reduced 12.84%	1,972,226 $10 Million
Q4 2021 Feb 14, 2022	SELL	$6.34 - $11.9 $1.5 Million - $2.82 Million	-237,158 Reduced 9.49%	2,262,842 $17.7 Million
Q3 2021 Nov 15, 2021	BUY	$5.75 - $11.21 $14.4 Million - $28 Million	2,500,000 New	2,500,000 $0

Others Institutions Holding CADL

# of Institutions

Shares Held

15.2M

Call Options Held

536K

Put Options Held

335K

View Full List

About Candel Therapeutics, Inc.

Ticker CADL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,891,900
Market Cap $170M
Description
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...

More about CADL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account